Human preprotachykinin gene promoter

Details Human preprotachykinin gene promoter Human preprotachykinin gene promoter

2008-03-11

2008-03-11

Yu, Misook (Department: 1642)

Chemistry: molecular biology and microbiology

Vector, per se

C536S024100, C435S325000

Reexamination Certificate

active

07341867

ABSTRACT:
Compositions and methods are provided for identifying novel therapeutic agents for the treatment of breast cancer, bone marrow metastasis, pain, arthritis, aggressive behavior, depression, and certain hematopoietic disorders. Disclosed are promoters and 3′ regulatory regions of genes whose expression differs in malignant cells as compared with non-malignant cells. These include PPT-I, NK-2 and SP-R.

REFERENCES:
patent: WO 87/07643 (1987-12-01), None
Bost, K.L. and Pascual, D.W., Substance P: a late-acting B lymphocyte differentiation cofactor. Am. J. Physiol. 262:C537-545 (1992).
Bunn, P.A. et al., Effects of Neuropeptide Analogues on Calcium Flux and Proliferation in Lung Cancer Cell Lines. Cancer Research 54:3602-3610 (1994).
Cremins, J.D. et al., Characterization of Substance P-Like Immunoreactivity and Tachykinin-Encoding mRNAs in Rat Medullary Throid Carcinoma Cell Lines. Journal of Neurochemistry 58:817-824 (1992).
Everard, M.J. et al., In vitro effects of substancePanalogue (D-Arg1, D-Phe5, D-Trp7,9, Leu11substancePon human tumour and normal cell growth. British Journal of Cancer 65:388-92 (1992).
GENEMBL accession No. S69719.
Gilchrist et al (DNA Cell Biol 10, 743-749 abstract only).
Hennig, I.M. et al., Substance-P Receptors in Human Primary Neoplasms: Tumoral and Vascular Localization. Int. J. Cancer 61:786-792 (1995).
Jones, D.A. et al., Processing [D-Arg1, D-Phe5, D-Trp7,9, Leu11] Substance P in Xeograft BearingNu/NuMice. Peptides 18:1073-1077 (1997).
McGregor, G.P. et al., Preprotachykinin-A Gene Expression Occurs Transiently in the Developing Rat Endocrine Pancreas and Can Be Regulated in RINm5F Cells. Endocrinology 136:2538-2546 (1995).
Moore, R.N. et al., Substance P Augmentation of CSF-1-Stimulated in vitro Myelopoiesis. The Journal of Immunology 141:2699-2703 (1988).
Rameshwar, Pranela et al.,Neural Regulation of Hematopoiesis by the Tachykinins, Implications for a “Fine Tuned” Hematopoietic Regulation, Molecular Biology of Hematopoiesis 5, pp. 463-470 (1996).
Rameshwar, Pranela et al.,Substance P(SP)Mediates Production of Stem Cell Factor and Interleukin-1 in Bone Marrow Stroma: Potential Autoregulatory Role for These Cytokines in SP Receptor Expression and Induction, Blood, vol. 86, No. 2 Jun. 15, 1995: pp. 482-490.
Rameshwar, Pranela et al.,Hematopoietic Regulation Mediated by Intearctions Among the Neurokinins and Cytokines, Leukemia and Lymphoma, vol. 28, pp. 1-10.
Ramshwar, Pranela et al.,Release and Interleukin-1 and Interleukin-6 From Human Monocytes by Antihymocyte Globulin: Requirement for De Novo Synthesis, Blood, vol. 80 Nov. 15, 1992: pp. 2531-2538.
Rameshwar, Pranela et al.,Molecule of the Month, Substance P: A Regulatory Neuropeptide for Hematopoiesis and Immune Functions1, Clinical Immunology and Immunopathology, vol. 85, No. 2, November, pp. 129-133, 1997, Article No. II974446.
Rameshwar, Pranela et al.,Induction of Negative Hematopoietic Regulators by Neurokinin-A in Bone Marrow Stroma, Blood, vol. 88, No. 1 Jul. 1, 1996: pp. 98-106.
Rameshwar, Pranela et al.,Receptor Induction Regulates the Synergistic Effects of Substance P with IL-1 and Platelet-Derived Growth Factor on the Proliferation of Bone Marrow Fibroblasts1, The Journal of Immunology, 1997, 158: 3417-3424.
Rameshwar, Pranela et al.,In Vitro Stimulatory Effect of Substance P on Hematopoiesis, Blood, vol. 81 Jan. 15, 1993: pp. 391-398.
Reeve, J.G. and Bleehen, N.M., [D-Arg1, D-Phe5, D-Trp7,9, Leu11] Substance P Induces Apoptosis in Lung Cancer Cell Lines in vitro. Biochemical and Phophysical Research Communications 199: 1313-1319 (1994).
Singh, Deeppreet et al.,Increased expressions of preprotachykinin-1 and neurokinin receptors in human breast cancer cells: Implications for bone marrow metastasis, PNAs, Jan. 4, 2000, vol. 97, No. 1, pp. 388-393.
Theodorsson-Norheim, E. et al., Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A (4-10) from a neutral water extract of a metastatic ileal carcinoid tumour. Eur. J. Biochem 166:693-695 (1987).
Webber, R.H. et al., Bone marrow response to stimulation of the sympathetic trunks in rats. Acta. anat. 77:9297 (1970).
Winkler, A. et al., Expression and characterization of the substance P (NK1) receptor in the rat pituitary and AtT20 mouse pituitary tumor cells. European Journal of Pharmacology 291: 51-55 (1995).
GENEMBL accession No. S69719, May 7, 1993.
Gilchrist et al (DNA Cell Biol 10, 743-749 abstract only), Dec. 1999.
Rameshwar, Pranela et al.,Hematopoietic Regulation Mediated by Intearctions Among the Neurokinins and Cytokines, Leukemia and Lymphoma, vol. 28, pp. 1-10, Dec. 1997.

Affiliated with

Also associated with

Rating

Human preprotachykinin gene promoter does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human preprotachykinin gene promoter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human preprotachykinin gene promoter will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2798884